Inhibition of miR-217 Protects Against Myocardial Ischemia –Reperfusion Injury Through Inactivating NF-κB and MAPK Pathways

ConclusionsMiR-217 inhibition protected against MIRI through inactivating NF- κB and MAPK pathways by targeting DUSP14. This study may provide valuable diagnostic and factors and therapeutic agents for MIRI.

http://link.springer.com/10.1007/s13239-019-00452-z

Source: Cardiovascular Engineering and Technology - January 7, 2020 Category: Cardiology Source Type: research